Torbay Pharma, founded in 1975, has established itself as a reputable entity in the United Kingdom's Manufacturing and Pharmaceutical sectors. Specializing in sterile injectable solutions for the hospital market, Torbay Pharma offers a strategic advantage by focusing on small to medium batch sizes tailored for generic pharmaceutical companies seeking efficient market entry.
Their slogan, "Reliable. Responsive. Ready.", underscores their commitment to being a dependable partner, offering agile solutions without the red tape often associated with larger Contract Development and Manufacturing Organizations (CDMOs). Emphasizing quality and compliance, their MHRA GMP-approved facility provides critical fill/finish services for terminally sterilized injectables.
In November 2023, Torbay Pharma secured a Private Equity Round investment led by NorthEdge Capital. This funding supports their ongoing expansion while maintaining an unwavering commitment to quality and strong client partnerships. Investors can view Torbay Pharma as a robust option in the sterile injectable manufacturing space.